Beta Drugs Limited — Others, 27-11-2024: Shareholders meeting

Beta Drugs Limited has announced a board meeting on December 21, 2024, to hold an Extraordinary General Meeting (EGM) at its registered office. Key items on the agenda include the adoption of restated articles of association and the appointment of two directors: Mr. Sanjay Sehgal as an Independent Director for five years and Mr. Ajay Mahipal as a Non-Executive Director. The updates could enhance governance and strategic oversight, potentially fostering a more positive outlook among investors as the company aligns with shareholder agreements and strengthens its leadership team.